Invention Grant
- Patent Title: Tricyclic fused thiophene derivatives as JAK inhibitors
-
Application No.: US14873078Application Date: 2015-10-01
-
Publication No.: US09908895B2Publication Date: 2018-03-06
- Inventor: Yun-Long Li , Wenyu Zhu , Song Mei , Joseph Glenn
- Applicant: Incyte Corporation , Incyte Holdings Corporation
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D495/12
- IPC: C07D495/12 ; C07D495/14 ; A61K31/437
Abstract:
The present invention provides tricyclic fused thiophene derivatives, as well as their compositions and methods of use, that modulate the activity of Janus kinase (JAK) and are useful in the treatment of diseases related to the activity of JAK including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.
Public/Granted literature
- US20160024109A1 TRICYCLIC FUSED THIOPHENE DERIVATIVES AS JAK INHIBITORS Public/Granted day:2016-01-28
Information query
